Pricing Log in Create free account

Akanda Corp. (AKAN) vs InMed Pharmaceuticals Inc. (INM)

Akanda Corp. and InMed Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $3.5M — 2.1× the size. Across the 7 metrics below, Akanda Corp. leads on 5 and InMed Pharmaceuticals Inc. on 2.

Valuation

Metric AKAN INM Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S n/m 0.95 2.11
P/B n/m 5.11 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 0.58 2.73
Earnings yield — (228.36%) (4.38%)
Free cash flow yield 0.00% (158.00%) 0.00%

Profitability

Metric AKAN INM Drug Manufacturers Specialty & Generic median
Gross margin — 26.27% 53.94%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (179.09%) (0.40%)
Return on assets 0.00% (139.63%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN INM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 19.38% 10.01%
EPS growth (last fiscal year) (139.63%) 62.68% 49.06%
Revenue growth, 5-year CAGR 161.77% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN INM Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.00 0.05
Current ratio 0.22 1.37 2.31
Net debt to EBITDA (2.75) 0.20 0.97

Dividend

Metric AKAN INM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AKAN INM Drug Manufacturers Specialty & Generic median
Market cap 3.45m 7.31m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack